Rallybio Ownership | Who Owns Rallybio?
Rallybio Ownership Summary
Rallybio is owned by 69.99% institutional investors, 4.06% insiders, and 25.95% retail investors. Viking global investors lp is the largest institutional shareholder, holding 10.29% of RLYB shares. abrdn Healthcare Investors is the top mutual fund, with 1.82% of its assets in Rallybio shares.
RLYB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Rallybio | 69.99% | 4.06% | 25.95% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Viking global investors lp | 4.19M | 10.29% | $5.62M |
| Johnson & johnson | 3.64M | 8.92% | $4.87M |
| 5am venture management | 3.63M | 8.90% | $4.87M |
| New leaf venture partners | 3.30M | 8.10% | $4.42M |
| Tpg gp a | 3.03M | 7.43% | $4.06M |
| Pivotal bioventure partners investment advisor | 2.40M | 5.90% | $3.22M |
| Fmr | 2.29M | 5.62% | $3.07M |
| Canaan partners xi | 2.06M | 5.05% | $2.76M |
| Abrdn | 1.73M | 4.24% | $2.31M |
| Vanguard group | 857.90K | 2.10% | $1.15M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| New leaf venture partners | 3.30M | 5.38% | $4.42M |
| Canaan partners xi | 2.06M | 3.34% | $2.76M |
| Pivotal bioventure partners investment advisor | 2.40M | 2.48% | $3.22M |
| Johnson & johnson | 3.64M | 1.22% | $4.87M |
| 5am venture management | 3.63M | 1.09% | $4.87M |
| Tpg gp a | 3.03M | 0.09% | $4.06M |
| Almitas capital | 100.88K | 0.06% | $135.17K |
| Viking global investors lp | 4.19M | 0.02% | $5.62M |
| Harbourvest partners | 21.88K | 0.02% | $29.32K |
| Point72 asia (singapore) pte. | 45.53K | 0.01% | $61.01K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Johnson & johnson | 3.64M | 1.22% | 3.64M |
| Millennium management | 459.97K | 0.00% | 263.19K |
| Goldman sachs group | 181.20K | - | 167.96K |
| Almitas capital | 100.88K | 0.06% | 100.88K |
| Susquehanna group, llp | 96.12K | - | 81.53K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 315.63K | - | -1.36M |
| State street | 65.22K | - | -448.50K |
| Blue owl capital lp | - | - | -350.24K |
| Geode capital management | 220.01K | - | -299.64K |
| Vanguard group | 857.90K | - | -218.88K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Johnson & johnson | 3.64M | 1.22% | 3.64M | $4.87M |
| Almitas capital | 100.88K | 0.06% | 100.88K | $135.17K |
| Qube research | 54.20K | 0.00% | 54.20K | $72.63K |
| Two sigma investments, lp | 53.25K | 0.00% | 53.25K | $71.36K |
| Point72 asia (singapore) pte. | 45.53K | 0.01% | 45.53K | $61.01K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -5.00 |
| Farther finance advisors | -9.00 |
| Nisa investment advisors | -25.00 |
| Amalgamated bank | -559.00 |
| Strs ohio | -1.60K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 49 | -20.97% | 31,212,752 | -1.30% | 69 | 1.16% | 14 | -56.25% | 22 | 46.67% |
| Jun 30, 2024 | 62 | 3.33% | 31,624,682 | 4.72% | 77 | 1.39% | 32 | 18.52% | 15 | -11.76% |
| Mar 31, 2024 | 60 | 11.11% | 30,199,996 | -4.89% | 74 | 1.22% | 27 | -3.57% | 17 | 54.55% |
| Dec 31, 2023 | 54 | -6.90% | 31,751,366 | 1.76% | 78 | 1.31% | 28 | 55.56% | 11 | -21.43% |
| Sep 30, 2023 | 58 | -1.69% | 31,203,674 | -6.19% | 77 | 1.13% | 18 | -48.57% | 14 | 40.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| abrdn Healthcare Investors | 755.08K | 1.82% | - |
| Vanguard Total Stock Mkt Idx Inv | 636.28K | 1.53% | - |
| abrdn Healthcare Opportunities | 594.62K | 1.43% | - |
| Fidelity Select Biotechnology | 581.09K | 1.40% | - |
| abrdn Life Sciences Investors | 377.38K | 0.91% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 248.74K | 0.60% | - |
| Fidelity Extended Market Index | 135.18K | 0.33% | 15.74K |
| Vifag 2002 SICAV | 100.00K | 0.24% | - |
| Bridgeway Ultra-Small Company Market | 87.40K | 0.21% | -4.60K |
| NT R2000 Value Index Fund - NL | 81.64K | 0.20% | -8.42K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 14, 2023 | Lieber Jonathan I | - | Buy | $26.05K |
| Mar 07, 2023 | PARMAR KUSH | - | Sell | $820.00K |
| Mar 07, 2023 | 5AM Partners V, LLC | - | Sell | $820.00K |
| Nov 15, 2022 | VIKING GLOBAL INVESTORS LP | - | Buy | $20.00M |
| Jun 03, 2022 | PARMAR KUSH | Sell | $1.25M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
| 2023 Q2 | - | - |
| 2023 Q1 | 1 | 2 |
| 2022 Q4 | 1 | - |
RLYB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools